QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 medpace-hldgs-raises-fy2025-gaap-eps-guidance-from-1376-1453-to-1460-1486-vs-1407-est-raises-fy2025-sales-guidance-from-2420b-2520b-to-2480b-2530b-vs-2464b-est

Medpace Hldgs (NASDAQ:MEDP) raises FY2025 GAAP EPS guidance from $13.76-$14.53 to $14.60-$14.86 vs $14.07 analyst estimate. Rai...

 medpace-hldgs-q3-eps-386-beats-352-estimate-sales-659903m-beat-640997m-estimate

Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $3.52 b...

 preview-medpace-hldgss-earnings
Preview: Medpace Hldgs's Earnings
10/21/2025 15:03:25

 mizuho-maintains-outperform-on-medpace-hldgs-raises-price-target-to-575

Mizuho analyst Ann Hynes maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $510 to $575.

 barclays-downgrades-medpace-hldgs-to-underweight-lowers-price-target-to-425

Barclays analyst Luke Sergott downgrades Medpace Hldgs (NASDAQ:MEDP) from Equal-Weight to Underweight and lowers the price t...

 jefferies-maintains-hold-on-medpace-hldgs-raises-price-target-to-450

Jefferies analyst David Windley maintains Medpace Hldgs (NASDAQ:MEDP) with a Hold and raises the price target from $400 to $...

 rothschild--co-downgrades-medpace-hldgs-to-neutral-raises-price-target-to-474

Rothschild & Co analyst Jamie Clark downgrades Medpace Hldgs (NASDAQ:MEDP) from Buy to Neutral and raises the price targ...

 ubs-downgrades-medpace-hldgs-to-sell-raises-price-target-to-305

UBS analyst Dan Leonard downgrades Medpace Hldgs (NASDAQ:MEDP) from Neutral to Sell and raises the price target from $300 to...

 thermo-fisher-baker-hughes-and-iqvia-holdings-are-among-top-10-large-cap-gainers-last-week-july-21-july-25-are-the-others-in-your-portfolio

Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.

 mizuho-maintains-outperform-on-medpace-hldgs-raises-price-target-to-510

Mizuho analyst Ann Hynes maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $328 to $510.

 truist-securities-maintains-hold-on-medpace-hldgs-raises-price-target-to-436

Truist Securities analyst Jailendra Singh maintains Medpace Hldgs (NASDAQ:MEDP) with a Hold and raises the price target from...

 deutsche-bank-maintains-hold-on-medpace-hldgs-raises-price-target-to-430

Deutsche Bank analyst Justin Bowers maintains Medpace Hldgs (NASDAQ:MEDP) with a Hold and raises the price target from $270 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION